David J Brooks MD DSc FRCP(UK) FMed Sci (UK) is Professor of Clinical PET Research at Newcastle University, Professor of Neurology at Aarhus University, Denmark, and Visiting Professor of Neurology at Imperial College London, UK. He is Chairman of the European Research Council Advanced Neuroscience Panel and is on the Grant Awards Board of Alzheimer Research UK, the Biomedical Research Advisory Panel of Alzheimer UK, and was on the Scientific Advisory Boards of Parkinson’s UK, and the German Dementia and the Parkinson Kompetenz Networks. He was Chairman of the NUHS Scientific Advisory Panel, Singapore, in 2015 and is a reviewer for the NMRC, Singapore. He was a member of the Scientific Advisory Board of the Michael J. Fox Foundation for Parkinson's Disease Research (2002-2006), UK Medical Research Council Neuroscience and Mental Health Board (2004-2007), Wellcome Trust Neuroscience Panel (2001-2003) and was Chairman of the Scientific Issues Committee of the Movement Disorder Society (1998-2002). He is an Associate Editor of Brain and is on the Editorial Boards of Annals of Neurology, Molecular Imaging and Biology, Journal of Parkinson’s Disease, Synapse, NPJ Parkinson’s Disease and Basal Ganglia. He was on the Editorial Boards of Movement Disorders 1994-1998 and Parkinsonism and Related Disorders 2012-2016. In 2001 he was elected a Fellow of the Academy of Medical Science, UK and is a Fellow of the American Neurology Association. His research involves the use of positron emission tomography and magnetic resonance imaging to diagnose and study the progression of Alzheimer’s and Parkinson’s disease and his work is highly cited with an h index of 112. He has been a recipient of the Ramon Y Cajal award from the Spanish Medical Academy, the Danish Alzheimer Foundation Prize, the Kuhl-Lassen award (Society of Nuclear Medicine), and was invited to give the Stahn Fahn (International Movement Disorder Society) and Cotzias (Spanish Neurology Society) and Ramon Y Cajal (Spanish Medical Academy) Lectures. He is currently a consultant for GE Healthcare and Biogen.

His research involves the use of positron emission tomography and magnetic resonance imaging to diagnose and study the progression of Alzheimer’s and Parkinson’s disease and his work is highly cited with an h index of 112.